APP Pharma nabs FDA nod for Zosyn copy; Ipsen in the market for new CFO;

@FiercePharma: France to stop paying for Pfizer's Champix. News | Follow @FiercePharma

> APP Pharmaceuticals won FDA approval to market a generic version Zosyn, Pfizer's injectable broad-spectrum antibiotic combining piperacillin and tazobactam. Report

> Ipsen's Claire Giraut, executive vice president and CFO, will leave her post as of September 1; the company will name a successor soon. Story

> Enzon Pharmaceuticals said it has named industry veteran Ana Stancic as senior vice president and chief financial officer. Article

> Bilfinger Berger has won a €30 million ($43 million) contract to help Genzyme add 8,000 liters of production capacity at its site in Geel, Belgium. Report

> Goldman Sachs analyst Mark Beards downgraded GlaxoSmithKline (GSK) today to "sell" from "neutral" on concerns that its above-average valuation doesn't jibe with its mediocre growth prospects and possible headwinds. Report

> SAC Capital Advisors is a focus of a Securities and Exchange Commission investigation into whether traders used inside information to profit from the $15 billion takeover of biotechnology firm MedImmune, people familiar with the matter say. Item

> Shares of AMAG Pharmaceuticals rose after an analyst upgraded the stock, saying he expects the stock price and sales of AMAG's drug Feraheme to recover. Article

> Bausch & Lomb intends to introduce a range of ophthalmic products in Indian market, as part of its plans to strengthen its presence globally. News

Biotech News

@FierceBiotech: Special Report: 5 emerging eClinical firms to watch. Article | Follow @FierceBiotech

@JohnCFierce: WSJ reports insider trading probe on SAC Capital and the MedImmune acquisition. Article | Follow @JohnCFierce

> Sanofi spurs layoff fears with Genzyme restructuring plans. News

> Novartis to showcase blockbuster cancer drug strategy at ASCO. Report

Drug Delivery News

> MAP Pharma files NDA for orally inhaled migraine treatment. Item

> Fluorescent carbon nanotubes light the way for drug-delivery researchers. Story

> Generex licenses buccal delivery to Amarantus for $10M. Report

> Why we love and hate the blood-brain barrier. Piece

> 'Theragnostic' nanoparticle detects and treats tumors. Article

> Packaging RNA for long-lasting, nontoxic delivery. Item

Medical Device News

> Boston Sci recalls imaging catheters. News

> Shuren to appear before House panel this week. Story

> Neoprobe sells gamma detection biz to Devicor. Item

> Advance Medical raises $6M in Series A. Article

And Finally... President Barack Obama's health care law, including its mandate that most Americans obtain insurance, goes before a U.S. appeals court, the second of at least three panels that will consider the act's constitutionality. Story

Suggested Articles

Seattle Genetics and Astellas’ newcomer Padcev now has what every cancer drugmaker is looking for: Randomized trial data showing it can extend lives.

A patent decision in Delaware clears the way for multiple generic companies to launch their Tecfidera copycats—and target its $3.3B in U.S. sales.

Sanofi and GlaxoSmithKline signed a deal with the EU to supply up to 300 million doses of their recombinant protein-based COVID-19 vaccine.